Former Freeman CMO alleges sex discrimination after raising compliance concerns
Amanda Harrell, DO, former chief medical officer of Freeman Health System in Joplin, Mo., has sued the organization in Jasper County Circuit Court, alleging she was fired because of her sex and in retaliation for raising compliance concerns tied to operations and physician oversight. The petition invokes the Missouri Human Rights Act and the Missouri Whistleblower Protection Act, placing the dispute squarely at the intersection of leadership authority, workplace equity and protected reporting.
The case is not a clinical malpractice dispute. It is a leadership and employment action centered on whether a senior physician executive was removed after escalating concerns about how the system was being run.
Dr. Harrell, 41, is an internist who joined Freeman in July 2016 and became CMO in December 2024. Before that promotion, she served as medical director of population health and chair of the division of medicine, roles that placed her close to the organization’s internal performance structure and compliance expectations. In the petition, she says she brought concerns in spring and summer 2025 to senior executives as well as to legal, risk and compliance teams.
Those concerns included contract mismanagement, gender-based pay inequity, radiology staffing, credentialing and ACGME compliance. In health systems, those are not isolated administrative complaints; they touch compensation fairness, physician workforce stability, training program integrity and the institution’s ability to meet accreditation standards. When a medical leader raises all of those issues at once, the dispute can quickly move beyond personnel management and into governance risk.
A brief exchange in July sits at the center of the filing.
On July 16, 2025, Freeman CEO Matthew Fry allegedly told Dr. Harrell she was “not the CMO he needed” and criticized her for “learning on the job.” The petition says Fry, who joined Freeman in April 2025, then offered her an undefined part-time leadership role. When she asked for the terms, he demanded an answer within about 30 minutes. Freeman terminated her on July 23, 2025.
One sentence in the petition carries the kind of abrupt career consequence that often defines executive retaliation claims: the CMO was gone within a week.
Dr. Harrell alleges that Freeman then placed a male physician with no prior CMO experience into the role. The complaint also says at least two other women in leadership were fired around the same time. In discrimination litigation, that combination — a challenged termination followed by replacement with a less experienced male physician and contemporaneous exits of other women leaders — is the kind of pattern plaintiffs often use to argue that sex played a role in employment decisions.
The filing does not establish those claims as facts. It does, however, frame the legal theory with unusual specificity: protected complaints, abrupt executive action, and a replacement decision that raises questions about how the organization judged qualifications and leadership continuity.
Employment law in a health system carries clinical consequences because leadership turnover affects staffing, credentialing, and training oversight long before it reaches a courtroom. Radiology coverage, for example, is not merely a scheduling issue; it can influence diagnostic turnaround and downstream patient flow. Credentialing failures can interrupt physician privileges or expose the organization to regulatory scrutiny. ACGME compliance affects the structure of graduate medical education, which in turn shapes supervision, duty-hour adherence and the training environment for residents and fellows.
In that sense, the allegations map onto core institutional functions. The alleged compliance concerns were not peripheral grievances. They involved the operating machinery of an academic and clinical system.
Dr. Harrell filed a charge with the Missouri Commission on Human Rights on Jan. 16, 2026, and received a right-to-sue notice on July 16, 2026. She is seeking more than $25,000 on each of three counts, reinstatement and a jury trial. Those remedies signal that the dispute is aimed not only at monetary recovery but also at restoration of professional standing inside the system.
Ryan McEnaney, Dr. Harrell’s legal representative, said in a statement shared with Becker’s that she was a long-term employee who served in multiple roles before being recruited to the CMO position. He said she won several awards, had an outstanding reputation in the community and consistently exceeded expectations before being wrongfully terminated.
The organization has not yet offered a public response in the material provided. Freeman has been contacted for comment.
Sex discrimination and whistleblower claims in medicine tend to test two overlapping questions: whether a physician executive was removed for performance-related reasons, and whether the timing and context of the termination suggest retaliation after protected reporting. The complaint in this case leans heavily on chronology. Dr. Harrell says she raised concerns in the spring and summer, then was confronted in mid-July and terminated one week later.
For hospital systems, those timelines matter because executive decisions can look clinical in origin while still carrying legal exposure. A new chief executive often re-evaluates senior leadership. A physician leader who has surfaced payment, staffing or compliance problems may suddenly find herself positioned as replaceable. When those events converge, courts and juries are asked to sort genuine performance management from protected-disclosure backlash.
This lawsuit now moves those questions into a public forum, with the outcome likely to turn on internal communications, personnel records, and the health system’s explanation for replacing a physician CMO with someone who allegedly had no prior CMO experience.